Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lemaitre Vascular (LMAT) Common Equity (2016 - 2025)

Lemaitre Vascular (LMAT) has disclosed Common Equity for 16 consecutive years, with $393.5 million as the latest value for Q4 2025.

  • Quarterly Common Equity rose 16.67% to $393.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $393.5 million through Dec 2025, up 16.67% year-over-year, with the annual reading at $393.5 million for FY2025, 16.67% up from the prior year.
  • Common Equity for Q4 2025 was $393.5 million at Lemaitre Vascular, up from $378.9 million in the prior quarter.
  • The five-year high for Common Equity was $393.5 million in Q4 2025, with the low at $177.5 million in Q1 2021.
  • Average Common Equity over 5 years is $291.8 million, with a median of $286.2 million recorded in 2023.
  • The sharpest move saw Common Equity soared 54.7% in 2021, then rose 4.9% in 2022.
  • Over 5 years, Common Equity stood at $254.2 million in 2021, then increased by 5.53% to $268.2 million in 2022, then increased by 11.07% to $297.9 million in 2023, then increased by 13.22% to $337.3 million in 2024, then increased by 16.67% to $393.5 million in 2025.
  • According to Business Quant data, Common Equity over the past three periods came in at $393.5 million, $378.9 million, and $362.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.